EUREKARE: eureKING, the first European SPAC in healthcare de

Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and a renowned player in the global biopharma and consumer health industries. The company's unique offer

Related Keywords

Paris , France General , France , Saint Quentin Fallavier , Rhôalpes , French , Christophe Jean , Benoit Mougeot , Stefan Berchtold , Calle Florence Coupry , Laurent Rigaudeau , Claris Avocats , Peter Eckenberg , Michael Kloss , Alexandre Mouradian , Oleron Pharma , Hubert Olivier , Xavier Mathiot , Guillaume Destison , Jacques Lewiner , Skyehub Bioproduction , David Lescuyer , Purpose Acquisition Company , Kingarticles Of Association , Fund Ltd , King Articles Of Association , Willkie Farr Gallagher , Aroma Health , Euronext Paris , Isabelle Cachard , Fonds De Renforcement , Rollover Shareholders , Market Shares , Initial Business Combination , Professional Segment , Initial Business , General Segment , Risk Factors , Skyehub Model , Contribution Prospectus , Initial Business Contribution , Purchase Agreement , Put Option Agreement , Contribution Share , Market Warrants , Put Option , Contribution Agreement , Des March , Founder Shares , Cornerstone Investors , Initial Founders , Secured Deposit Accounts , Founder Warrants , Ordinary Shares , French Code , Willkie Farr , Special Purpose Acquisition Company , Sergio De La Calle , Florence Coupry , Rodolphe Besserve , Gefallene Big Techs , Eurekare , Zureking , First , European , Pac , Healthcare , Edicated , Biomanufacturing , Nnounces , Signature , Option , Potential , Cquisition , Skyepharma , Build , Dmo , Leader ,